Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratioviaAIB1 or SMRT recruitment to theCCND1andMYCpromoters

Novel, Low Cost, Highly Effective, Handmade Steroid Pellets for Experimental Studies

(2013) Ana Sahores et al.   PLoS One

Estrogen Receptor Alpha Mediates Progestin-Induced Mammary Tumor Growth by Interacting with Progesterone Receptors at the Cyclin D1/MYC Promoters

(2012) S. Giulianelli et al.   CANCER RESEARCH

Antiprogestins in breast cancer treatment: are we ready?

(2012) Claudia Lanari et al.   ENDOCRINE-RELATED CANCER

Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line

(2012) Junaid A. Khan et al.   PLoS One

Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression

(2011) Chelsea R Tieszen et al.   BMC CANCER

Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer

(2011) J. P. Cerliani et al.   CANCER RESEARCH

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas

(2010) Victoria Wargon et al.   BREAST CANCER RESEARCH AND TREATMENT

CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis

(2010) R. Wiehle et al.   Cancer Prevention Research

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

(2010) Ingrid Nilsson et al.   EMBO JOURNAL

Cooperative Activation of Cyclin D1 and Progesterone Receptor Gene Expression by the SRC-3 Coactivator and SMRT Corepressor

(2010) Sudipan Karmakar et al.   MOLECULAR ENDOCRINOLOGY

Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells

(2010) E. F. Farias et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aglepristone (RU534) administration to non-pregnant bitches in the mid-luteal phase induces early luteal regression

(2010) A. Polisca et al.   THERIOGENOLOGY

Nuclear Receptor Coregulators in Cancer Biology

(2009) B. W. O'Malley et al.   CANCER RESEARCH

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer

(2009) Claudia Lanari et al.   ENDOCRINE-RELATED CANCER

Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer

(2009) Kakoli Das et al.   EUROPEAN JOURNAL OF CANCER

Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice

(2009) Ariana Bruzzone et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas

(2008) Victoria Wargon et al.   BREAST CANCER RESEARCH AND TREATMENT

ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

(2008) Jiang Fan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY